Loading...
Cookies & Privacy. This website uses cookies to ensure you get the best experience on our website.
One Product, Two Indications

Providing surgeons with a solution throughout the continuum of soft tissue repair

Restrata for Soft Tissue Reinforcement is indicated for implantation to reinforce soft tissue where weakness exists, in patients requiring soft tissue repair and/or reinforcement in plastics or reconstructive surgery. 14

What is Soft Tissue Reinforcement?

Restrata for Soft Tissue Reinforcement is indicated for implantation to reinforce soft tissue where weakness exists, in patients requiring soft tissue repair and/or reinforcement in plastics or reconstructive surgery. 14

Product Benefits

  • Offers mechanical support for closures that may be at risk of wound breakdown or dehiscence
  • Designed to mitigate wound breakdown or dehiscence, potentially reducing complications in high-risk patients and threatened closures 14, 15, 20, 21​
  • Tensile strength similar to human skin and maintains some strength for 7-10 days after implantation, reinforcing subcutaneous closure during the 5-10 day window where the risk of dehiscence is the greatest 2, 22-24, 28, 31

Addressing Clinical Needs

By maintaining mechanical strength through this critical period of healing22, Restrata addresses a key driver of surgical site complications20 — issues that significantly extend hospital stays and increase costs, as shown in the study below:

Incidence and impact of surgical site complications on length of stay and cost of care for patients undergoing open procedures20

“Surgical site complications (SSCs) such as dehiscence, postoperative seroma, skin complications and non-healing wounds can be serious and even life-threatening for patients and often result in increased health care utilization.”

Non-infectious SSC rates were ~5% in this retrospective analysis of Medicare and Premier data.
Total incremental LOS per non-infectious SSC was 6.5 days in Medicare Patients
Total incremental LOS per non-infectious SSC was 5.2 days for Premier patients
Surgical site complications, particularly non-infectious SSCs, are not uncommon in open procedures and result in increased LOS and costs.

_________________________________________

 

Surgical Techniques for Restrata in Soft Tissue Reinforcement

 

STR_video_images.png

 

size_chart4.png

 

References can be found on this page

Contact us to learn more

Get company updates and case studies delivered to your inbox
Sign Up
Revolutionizing Healing. Changing Lives.
  •  
Cerafix®, Covora®, and Restrata® are registered trademarks of Acera Surgical Inc.
  •